CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine S ME, A B, H C, D A, HS Müller Journal of Clinical Pharmacy and Therapeutics 31 (5), 493-502, 2006 | 303 | 2006 |
Metabolomics of type 1 and type 2 diabetes B Arneth, R Arneth, M Shams International journal of molecular sciences 20 (10), 2467, 2019 | 232 | 2019 |
The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers AM Moghazy, ME Shams, OA Adly, AH Abbas, MA El-Badawy, ... Diabetes research and clinical practice 89 (3), 276-281, 2010 | 159 | 2010 |
Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt MEE Shams, EAME Barakat Saudi Pharmaceutical Journal 18 (4), 225-232, 2010 | 153 | 2010 |
Adherence to medication among outpatient adolescents with epilepsy WM Gabr, MEE Shams Saudi Pharmaceutical Journal 23 (1), 33-40, 2015 | 150 | 2015 |
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels G Hefner, MEE Shams, S Unterecker, T Falter, C Hiemke Psychopharmacology 233, 1695-1705, 2016 | 93 | 2016 |
Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines MEE Shams, MMH Al-Gayyar, EAME Barakat Scientia pharmaceutica 79 (3), 623-634, 2011 | 75 | 2011 |
Collection, storage and use of blood samples for future research: views of Egyptian patients expressed in a cross-sectional survey A Abou-Zeid, H Silverman, M Shehata, M Shams, M Elshabrawy, ... Journal of medical ethics 36 (9), 539-547, 2010 | 61 | 2010 |
Protective effects of arjunolic acid against cardiac toxicity induced by oral sodium nitrite: effects on cytokine balance and apoptosis MMH Al-Gayyar, A Al Youssef, IO Sherif, MEE Shams, A Abbas Life sciences 111 (1-2), 18-26, 2014 | 49 | 2014 |
Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry C Hiemke, M Shams Current drug delivery 10 (1), 46-53, 2013 | 41 | 2013 |
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine M Grözinger, A Dragicevic, C Hiemke, M Shams, MJ Müller, S Härtter Pharmacopsychiatry 36 (01), 3-6, 2003 | 38 | 2003 |
Therapeutic drug monitoring of the antidepressant mirtazapine and its N-demethylated metabolite in human serum M Shams, C Hiemke, S Härtter Therapeutic drug monitoring 26 (1), 78-84, 2004 | 36 | 2004 |
Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease MMH Al-Gayyar, MEE Shams, EAME Barakat Pharmaceutical Biology 50 (3), 297-303, 2012 | 34 | 2012 |
Paroxetine serum concentrations in depressed patients and response to treatment. HC Gilles M, Deuschle M, Kellner S, Shams M, Krumm B Pharmacopsychiatry 38 (3), 118-121, 2005 | 34 | 2005 |
Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives AM Hamdan, MM Al-Gayyar, MEE Shams, US Alshaman, K Prabahar, ... Scientific reports 9 (1), 7026, 2019 | 32 | 2019 |
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene B Arneth, M Shams, C Hiemke, S Härtter Clinical biochemistry 42 (12), 1282-1290, 2009 | 30 | 2009 |
Rating the delirogenic potential of drugs for prediction of side effects in elderly psychiatric inpatients G Hefner, M Shams, K Wenzel-Seifert, A Fellgiebel, T Falter, E Haen, ... JJ Pharma Pharmacovigilance 1 (1), 003, 2015 | 20 | 2015 |
Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey G Hefner, S Unterecker, MEE Shams, M Wolf, T Falter, E Haen, C Hiemke Journal of Neural Transmission 122, 1609-1617, 2015 | 18 | 2015 |
Retrospective pilot study for analysis of antidepressant serum concentrations of citalopram and venlafaxine during inflammation G Hefner, MEE Shams, S Unterecker, T Falter, C Hiemke Pharmacopsychiatry 25 (06), 215-218, 2015 | 10 | 2015 |
Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma MEES Mohammed M.H. Al-Gayyara, Mohamed A. Ebrahim Journal of Pharmacy Research, 2013 | 8 | 2013 |